One Fibrodysplasia Ossificans Progressiva Trial is on Hold but Another has Shown Promise
Ipsen is a pharmaceutical company based out of Paris. Sadly, they have just announced that they have pressed pause on not one but two studies for fibrodysplasia ossificans progressiva (FOP). FOP…